Japan Animal Referral Medical Center Co., Ltd. Fundamental Analysis (JPX: 6039.T)
Japan Animal Referral Medical Center Co., Ltd. Fundamental Analysis (JPX: 6039.T)
Japan Animal Referral Medical Center Co., Ltd. (JPX: 6039.T) shows moderate financial fundamentals with a PE ratio of 15.20, profit margin of 14.03%, and ROE of 18.77%. The company generates $6.4B in annual revenue with strong year-over-year growth of 17.33%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 58.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 6039.T's fundamental strength across five key dimensions:
Efficiency Score
Weak6039.T struggles to generate sufficient returns from assets.
Valuation Score
Excellent6039.T trades at attractive valuation levels.
Growth Score
Excellent6039.T delivers strong and consistent growth momentum.
Financial Health Score
Weak6039.T carries high financial risk with limited liquidity.
Profitability Score
Weak6039.T struggles to sustain strong margins.
Key Financial Metrics
Is 6039.T Expensive or Cheap?
P/E Ratio
6039.T trades at 15.20 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 6039.T's PEG of 0.31 indicates potential undervaluation.
Price to Book
The market values Japan Animal Referral Medical Center Co., Ltd. at 2.74 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.35 times EBITDA. This is generally considered low.
How Well Does 6039.T Make Money?
Net Profit Margin
For every $100 in sales, Japan Animal Referral Medical Center Co., Ltd. keeps $14.03 as profit after all expenses.
Operating Margin
Core operations generate 19.50 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.77 in profit for every $100 of shareholder equity.
ROA
Japan Animal Referral Medical Center Co., Ltd. generates $7.95 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Japan Animal Referral Medical Center Co., Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Japan Animal Referral Medical Center Co., Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
6039.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.20
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.31
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.74
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.13
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.04
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.54
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.19
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.16
vs 25 benchmark
How 6039.T Stacks Against Its Sector Peers
| Metric | 6039.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.20 | 25.68 | Better (Cheaper) |
| ROE | 18.77% | 970.00% | Weak |
| Net Margin | 14.03% | -4902.00% (disorted) | Strong |
| Debt/Equity | 1.04 | 0.60 | Weak (High Leverage) |
| Current Ratio | 0.54 | 2.33 | Weak Liquidity |
| ROA | 7.95% | 321.00% | Weak |
6039.T outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Japan Animal Referral Medical Center Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
98.72%
Industry Style: Cyclical, Growth, Discretionary
High GrowthEPS CAGR
167.07%
Industry Style: Cyclical, Growth, Discretionary
High GrowthFCF CAGR
152.90%
Industry Style: Cyclical, Growth, Discretionary
High Growth